Cathy Fernandes Selected Research

Cathy Fernandes Research Topics

Disease

3	Intellectual Disability (Idiocy) 04/2024 - 01/2013
3	Inflammation (Inflammations) 10/2022 - 01/2018
2	Autistic Disorder (Autism) 01/2023 - 01/2013
2	Body Weight (Weight, Body) 10/2022 - 01/2021
2	Autism Spectrum Disorder 01/2021 - 01/2015
2	Mood Disorders (Mood Disorder) 01/2018 - 12/2011
2	Neurodevelopmental Disorders 12/2017 - 01/2015
2	Schizophrenia (Dementia Praecox) 01/2015 - 01/2013
2	Alcoholism (Alcohol Abuse) 10/2014 - 10/2014
2	Alzheimer Disease (Alzheimer's Disease) 08/2014 - 08/2012
2	Infections 01/2013 - 01/2011
1	Premature Birth (Birth, Premature) 10/2022
1	Asthma (Bronchial Asthma) 10/2022
1	Brain Diseases (Brain Disorder) 10/2022
1	Seizures (Absence Seizure) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Obesity 01/2019
1	Necrosis 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Cicatrix (Scar) 01/2017
1	CHARGE Syndrome 01/2017
1	Major Depressive Disorder (Major Depressive Disorders) 05/2014
1	Substance-Related Disorders (Drug Abuse) 09/2013
1	Bacterial Meningitis 01/2013
1	Neoplasms (Cancer) 09/2012
1	Bipolar Disorder (Manic Depressive Psychosis) 12/2011
1	Hyperalgesia 03/2008

Drug/Important Bio-Agent (IBA)

2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 05/2014
2	Guanine Nucleotide-Releasing Factor 2IBA 10/2014 - 10/2014
2	RNA (Ribonucleic Acid)IBA 01/2013 - 01/2011
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	Histone DemethylasesIBA 04/2024
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 10/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 10/2022
1	ParvalbuminsIBA 10/2022
1	montelukast (Singulair)FDA Link 10/2022
1	Tight Junction ProteinsIBA 01/2022
1	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	CorticosteroneIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2019
1	LipopolysaccharidesIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	CytokinesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 12/2017
1	Actins (F Actin)IBA 01/2017
1	ENA-VASP proteins (Ena-VASP-homology proteins)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	ChromatinIBA 01/2017
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2015
1	gamma-Aminobutyric Acid (GABA)IBA 01/2015
1	Glutamic Acid (Glutamate)FDA Link 01/2015
1	5-hydroxymethylcytosineIBA 08/2014
1	5-Methylcytosine (5 Methylcytosine)IBA 08/2014
1	Imipramine (Janimine)FDA LinkGeneric 05/2014
1	Fluoxetine (Prozac)FDA LinkGeneric 05/2014
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	Phosphotransferases (Kinase)IBA 09/2012
1	MicroRNAs (MicroRNA)IBA 09/2012
1	CholesterolIBA 08/2012
1	Amyloid (Amyloid Fibrils)IBA 08/2012
1	LipidsIBA 08/2012
1	Peptides (Polypeptides)IBA 08/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2011
1	monomethylpropion (methcathinone)IBA 01/2011
1	Cholecystokinin (Pancreozymin)IBA 03/2008
1	2,5-dichloro-4-bromophenol (B 2)IBA 03/2008

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2015
1	Injections 01/2018